PharmaTher Announces Application with the FDA for Ketamine in the Treatment of Parkinson’s Disease

Featured Articles

Analysis

What Oregon’s Measure 109 Means for Hopeful Entrepreneurs and Investors

While entrepreneurs and investors are likely to see Oregon’s Measure 109 as a chance to capitalize on new business opportunities and investments, it’s worth highlighting that this new law is unlikely to lead to a psilocybin gold rush.

Feb 9 • 6 min read

Press

PharmaTher Announces Application with the FDA for Ketamine in the Treatment of Parkinson’s Disease

PharmaTher Holdings Ltd. today announced it submitted an Investigational New Drug application with the U.S. Food and Drug…

Apr 20 • 5 min read

Press

Cybin Establishes Clinical Advisory Board of Renowned Physicians

Cybin Inc. today announced the formation of its Clinical Advisory Board.

Apr 19 • 5 min read

Press

Ehave to Launch Ketamine Trials Using Brain Mapping Technology

Ehave, Inc. announced plans to launch brain mapping ketamine clinical trials using Brain Scientific technology later this year.

Apr 16 • 6 min read

Press

Silo Wellness Announces Intellectual Property Licensing Agreement of Psilocybin Nasal Spray in Colombia and Brazil

Quick Take: Silo Wellness entered into an agreement with Jungle Med to distribute and sell their psilocybin nasal…

Apr 15 • 4 min read

Analysis

New Research Confirms Multi Billion Dollar Investment Opportunity in Psychedelic Medicine

Even though it is a nascent industry, already hundreds of millions of dollars have been poured into the…

Apr 15 • 4 min read

Track the entire psychedelic market using the only index that covers the entire psychedelics marketplace.

Explore the Index

All Articles

All
Analysis
Interviews
Press

Business

This Danish Psychedelic Company Turns Yeast Into Psilocybin

May 14 • 1 min read

Most of us associate yeast as the key ingredient for making bread. Of course beer and wine also rely on yeast to convert sugar into alcohol. More recently, yeast has been used to create THC, CBD, and several other cannabinoids in laboratories. This has allowed scientists to create ‘lab grown’ cannabis products. Now, a synthetic […]

Lifestyle

The Future of Treating Mental Health with Psychedelics

Apr 17 • 2 min read

Psychedelic medicine continues to show real promise as treatment for mental illnesses. There has been an overwhelming amount of positive results in patients with Alzheimer’s, PTSD, depression anxiety, and addiction. In this article we will dive into how psychedelics help treat psychiatric illnesses and the future of the industry. Over the past decade there has […]

Business

Former Red Bull exec joins psychedelic company

Apr 17 • 1 min read

Jim Bailey, the former president of Red Bull Canada, has joined the special advisory committee of psychedelic company Champignon Brands. “I am very excited to be part of a company that is leading the way in finding alternative solutions to traditional pharmaceuticals with science based research and functional products,” commented Jim Bailey. “My background in […]

Business

MindMed gets upgraded trading status

Apr 17 • 1 min read

Psychedelic pharmaceutical company, MindMed, has begun trading on the OTCQB Venture Market as of April 17th, 2020. This is an upgrade to where they were previously trading in the U.S., on the OTC Pink Open Market, indicating the progress the company is making. “We are very excited to start trading on the OTCQB as it […]

Analysis

Patent Filed on Psilly: A Unique Psilocybin Blend

Apr 14 • 1 min read

Orthogonal is a Hawaiian based holding company focused on health and well-being products. In April of 2020, Orthogonal finished filing a U.S. provisional patent application on a new product called Psilly. The patent is for a unique psilocin blend with natural alkaloids. Orthogonal plans on making it a flagship natural product in the psychedelic space. […]

Pages: First Page123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475Last Page